US expands AbbVie Roche\'s Venclexta for use in combination with Gazyva in patients with previously untreated CLL httpsfirstwordpharma.comnode1641248tsid28®ionid6Â

US expands AbbVie, Roche's Venclexta for use in combination with Gazyva in patients with previously untreated CLL https://firstwordpharma.com/node/1641248?tsid=28®ion_id=6 …

16:28 EDT 15 May 2019 | FirstWord Pharma

US expands AbbVie, Roche's Venclexta for use in combination with Gazyva in patients with previously untreated CLL https://firstwordpharma.com/node/1641248?tsid=28&region_id=6 …

More From BioPortfolio on "US expands AbbVie, Roche's Venclexta for use in combination with Gazyva in patients with previously untreated CLL https://firstwordpharma.com/node/1641248?tsid=28®ion_id=6 …"